Prevalence and factors affecting glucosamine use in Korea: A survey-based study

Rheumatology International

Volumn 33, Issue 6, 2013, Pages 1627-1631

  Seo, Hyun Ju ^a   Sung, Yoon Kyoung ^b   Choi, Chan Bum ^b   Lee, Eun Bong ^c   Cheong, Chelim ^d   Kim, Soo Young ^e   Park, Ji Ae ^d   Bae, Sang Cheol ^b  

^a Chosun University   (South Korea)

^b Hanyang University Hospital for Rheumatic Diseases   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d National Evidence Based Healthcare Collaborating Agency   (South Korea)

^e Hallym University College of Medicine   (South Korea)

Author keywords

Chondroitin; Glucosamine; Medication practices; Prevalence

Indexed keywords

CHONDROITIN; GLUCOSAMINE;

ADULT; ADVERTIZING; AGED; ARTHRITIS; ARTICLE; CARTILAGE; DRUG INFORMATION; DRUG USE; FEMALE; HEALTH SURVEY; HUMAN; INTERNET; KOREA; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PAIN; PREVALENCE; PRIORITY JOURNAL; STRUCTURED QUESTIONNAIRE; TELEVISION;

ADULT; AGED; CHONDROITIN; CROSS-SECTIONAL STUDIES; DIETARY SUPPLEMENTS; FEMALE; GLUCOSAMINE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS; REPUBLIC OF KOREA;

EID: 84878693079     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-2288-x     Document Type: Article

References (18)

1. Kim H, Kim M (2009) A study of the demographic characteristics and socio-psychological factors affecting willingness to take health foods among elderly. Korean Assoc Human Ecol 18:201-210 Korean
2. Korea Food & Drug Administration (2008) Food & drug statistical yearbook. Republic of Korea, Seoul: Korea Food & Drug Administration, Korean
3. Herman CJ, Allen P, Hunt WC, Prasad A, Brady TJ (2004) Use of complementary therapies among primary care clinic patients with arthritis. Prev Chronic Dis 1:A12. doi: 10.1002/art.21443
4. Kim H, Kim M (2009) A study of the demographic characteristics and socio-psychological factors affecting willingness to take health foods among elderly. Korean Assoc human ecology 18:201-210 Korean
5. Blakeley JA, Ribeiro V (2002) A survey of self-medication practices and perceived effectiveness of glucosamine products among older adults. Complement Ther Med 10:154-160. doi: 10.1016/S0965229902000559
6. Marinac JS, Buchinger CL, Godfrey LA, Wooten JM, Sun C, Willsie SK (2007) Herbal products and dietary supplements: a survey of use, attitudes, and knowledge among older adults. J Am Osteopath Assoc 107:13-20
7. Jordan KM, Sawyer S, Coakley P, Smith HE, Cooper C, Arden NK (2004) The use of conventional and complementary treatments for knee osteoarthritis in the community. Rheumatology (Oxford) 43:381-384. doi: 10.1093/rheumatology/keh045
8. Blakeley JA, Ribeiro V (2002) A survey of self-medication practices and perceived effectiveness of glucosamine products among older adults. Complement Ther Med 10:154-160. doi: 10.1016/S0965229902000559
9. Towheed T, Maxwell L, Anastassiades TP, Shea B, Houpt J, Welch V, Hochberg MC, Wells GA (2005) Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev Issue 2. Art. No.: CD002946. doi: 10.1002/14651858.CD002946.pub2
10. Black C, Clar C, Henderson R, MacEachern C, McNamee P, Quayyum Z, Royle P, Thomas S (2009) The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: a systematic review and economic evaluation. Health Technol Assess 13:1-148
11. Vlad SC, LaValley MP, McAlindon TE, Felson DT (2007) Glucosamine for pain in osteoarthritis: why do trial results differ? Arthritis Rheum 56:2267-2277. doi: 10.1002/art.22728
12. Wandel S, Jüni P, Tendal B, Nüesch E, Villiger PM, Welton NJ, Reichenbach S, Trelle S (2010) Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ 341:c4675. doi: 10.1136/bmj.c4675
13. Samson DJ, Grant MD, Ratko TA, Bonnell CJ, Ziegler KM, Aronson N (2007) Treatment of primary and secondary osteoarthritis of the knee. Evid Rep Technol Assess 1-157
14. American Academy of Orthopaedic Surgeons (AAOS) (2008) American Academy of Orthopaedic Surgeons treatment of osteoarthritis of the knee (non-arthroplasty) (1st ed) Illinois: Author. http://www.aaos.org/research/ guidelines/oakguideline.pdf
15. Zhang W, Nuki G, Moskowitz RW, Abramson S, Altman RD, Arden NK, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P (2010) OARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthr Cartil 18:476-499. doi: 10.1016/j.joca.2010.01.013
16. Sarnsamak P (2011) FDA to support controversial drugs. The Nation February 24, 2011 12:00 pm http://www.nationmultimedia.com/2011/02/24/national/ FDA-to-support-controversial-drugs-30149419.html. Accessed 14 Nov 2011
17. Danish Medicines Agency (2011) The reimbursement for glucosamine is removed on 28 November 2011. http://laegemiddelstyrelsen.dk/en/topics/ statistics,-prices-and-reimbursement/reimbursement-of-medicines/ general-reimbursement/reassessment/news/the-reimbursement-for-glucosamine-is- rem - ember-2011 Accessed 14 November 2011
18. Swedish Dental and Pharmaceutical Benefits agency (2011) Glucosamine excluded from the pharmaceutical benefits scheme. http://www.tlv.se/in-english- old/news/glucosamine-excluded-from-the-pharmaceutical-benefits-scheme/ Accessed 14 Nov 2011